Beisol Pharma Meerle SPRL
Beisol Pharma Meerle reported revenue of 20,480 € for the 2026 financial year (annual accounts filed with the NBB on 05 Oct 2026).
The score of Beisol Pharma Meerle shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2026
Change 2023 → 2026: Revenue -56 % Total assets -33 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Beisol Pharma Meerle's annual accounts
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | 20,480 € | ||||
| Net result | 10,337 € | ||||
| Equity | −61,896 € | ||||
| Cash | 31 € | ||||
| EBITDA | 10,393 € | ||||
| Total assets | 128,773 € |
Filed annual accounts
- Year ended 31 Mar 2026filed on 05 Oct 2026
- Year ended 31 Mar 2025filed on 21 Oct 2025
- Year ended 31 Mar 2024filed on 15 Oct 2024
- Year ended 31 Mar 2023filed on 23 Oct 2023
- Year ended 31 Mar 2022filed on 17 Oct 2022
Beisol Pharma Meerle's financial analysis
- Solvency-48.1%sector median: 58.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Beisol Pharma Meerle
Beisol Pharma Meerle's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0544.650.644
- VAT number
- BE0544650644
- Peppol
- Registered · 0208:0544650644 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 22 Jan 2014
- Registered office
- 3210 Lubbeek
- Latest accounts
- 2026 · filed on 05 Oct 2026
- Activity
- Leasing of intellectual property and similar products, except copyrighted works (NACE 77400)
Beisol Pharma Meerle (SPRL) has been based in Lubbeek since 2014, active in: leasing of intellectual property and similar products, except copyrighted works. For 2026, it reports revenue of 20,480 €, a net profit of 10,337 € and equity of −61,896 €. Its solvency stands at -48.1%, below the median of its sector (58.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Beisol Pharma Meerle
Companies in the same business, of comparable size and area, outside its group.
- Molipoly Leasing of intellectual property and similar products, except copyrighted works Herent · balance sheet 469,424 €
- Skol International Development Leasing of intellectual property and similar products, except copyrighted works Watermael-Boitsfort · balance sheet €9.34m
- Base Holding Leasing of intellectual property and similar products, except copyrighted works Saint-Gilles · balance sheet 763,584 €
- DYMO Leasing of intellectual property and similar products, except copyrighted works Sint-Niklaas · balance sheet €17.9m
- DELI Leasing of intellectual property and similar products, except copyrighted works Erpe-Mere · balance sheet €9.66m
- Classic Confectionery Brands Leasing of intellectual property and similar products, except copyrighted works Ixelles · balance sheet 206,666 €
- Nevam Leasing of intellectual property and similar products, except copyrighted works Alveringem · balance sheet €1.29m
- Apotheek Vanhoutte Leasing of intellectual property and similar products, except copyrighted works Kortrijk · balance sheet 283,445 €
Frequently asked questions about Beisol Pharma Meerle
What is the revenue of Beisol Pharma Meerle?
According to the 2026 annual accounts filed with the NBB, the revenue of Beisol Pharma Meerle amounts to 20,480 €.
What is the VAT number of Beisol Pharma Meerle?
In Belgium, the VAT number is the company number prefixed with BE: BE0544650644 for Beisol Pharma Meerle, if the company is VAT-registered. Its company number (CBE) is 0544.650.644.
Where is the registered office of Beisol Pharma Meerle?
According to the CBE register, the registered office of Beisol Pharma Meerle is in 3210 Lubbeek.
What is the equity of Beisol Pharma Meerle?
At the close of the 2026 financial year, the equity of Beisol Pharma Meerle amounts to -61,896 €, a solvency of -48.1% of total assets.
Who manages Beisol Pharma Meerle?
The register lists 2 active mandates at Beisol Pharma Meerle. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Beisol Pharma Meerle
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →